Notice NOT-OH-21-002 from the NIH Guide for Grants and Contracts

Notice NOT-OH-21-003 from the NIH Guide for Grants and Contracts

Notice NOT-HD-20-033 from the NIH Guide for Grants and Contracts

Notice NOT-HD-20-029 from the NIH Guide for Grants and Contracts

Notice NOT-TR-20-037 from the NIH Guide for Grants and Contracts

Notice NOT-RM-20-025 from the NIH Guide for Grants and Contracts

Covance: Job Overview:Lead Project Data Manager, FSPpermanent, salariedRemote from anywhere in the U.S. or CanadaGet ahead in your career and make a difference Ottawa (Region), Ontario (CA)

Covance: Job Overview:Lead Project Data Manager, FSPpermanent, salariedRemote from anywhere in the U.S. or CanadaGet ahead in your career and make a difference New York (State) (US)

BS in life science, biochemistry or chemistry. We know that behind every scientific breakthrough, there is a deep infrastructure of talented individuals driving…
From 10X Genomics - Fri, 18 Sep 2020 12:24:44 GMT - View all Wisconsin jobs

Competitive with benefits, subject to skills and experience: The Francis Crick Institute: A postdoctoral position is available in the laboratory of Dr. Rashmi Priya at the Francis Crick institute. London (Central), London (Greater) (GB)

Funding Opportunity PAR-20-301 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support intramural-extramural collaborations on late-stage translational science projects between NCATS Therapeutic Development Branch (TDB) and extramural researchers, for therapeutic development of small molecules, biologics, or gene therapies. The UG3 phase will provide support for late stage pre-clinical work and clinical trial planning that is conducted at applicant institutions. The goal of any collaboration with TDB is to enable an IND application by the end of the UG3 phase. If UG3 milestones are met and an IND is cleared, support may be provided for an early stage clinical trials in the UH3 phase that will be conducted at the applicant institutions.

Funding Opportunity RFA-CA-20-043 from the NIH Guide for Grants and Contracts. Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) invites multiple-PD/PI applications for collaborative research projects that will comprise a new incubator program within the Cancer Intervention and Surveillance Modeling Network (CISNET). The overarching goal of this FOA is to expand comparative simulation modeling approaches developed by CISNET to cancer sites beyond the sites which have been previously funded under CISNET (breast, colorectal, prostate, lung, esophageal, and cervical). This "incubator" FOA is open to any cancer site beyond these sites. Specifically, this program aims to translate CISNETs framework of success to cancer sites that are not already part of the CISNET and for which there has been nascent/limited population modeling and little to no comparative modeling. For this FOA, "incubate" refers to accelerating the development and application of CISNET-type models for new cancer sites. Accelerating the development of comparative simulation modeling approaches for new cancer sites beyond those already funded is expected to generate sophisticated, evidence-based decision tools that could inform decisions on the most efficient utilization of existing and emerging technologies and strategies for the control of proposed cancers. While open to all qualified investigators, to encourage broad participation from population modelers in cancer control, this FOA will allow no more than one Principal Investigator who is funded under the CISNET FOA RFA-CA-19-054 to also be a Principal Investigator on each Incubator application.

MS or PhD student in Animal Science, Dairy Science, Quantitative Genetics, Computer Science, Statistics or related field, required;
From ABS Global - Thu, 17 Sep 2020 23:12:40 GMT - View all DeForest, WI jobs

MS or PhD student in Animal Science, Dairy Science, Quantitative Genetics, Computer Science, Statistics or related field, required;
From ABS Global - Thu, 17 Sep 2020 23:12:40 GMT - View all DeForest, WI jobs

Funding Opportunity PAR-20-289 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this NIAID R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs of NIAID mission areas.

Funding Opportunity RFA-MH-20-556 from the NIH Guide for Grants and Contracts. This FOA is related to the transformative project, "A Cell Type-Specific Armamentarium for Understanding Brain Function and Dysfunction," described in the "The BRAIN Initiative 2.0: From Cells to Circuits, Toward Cures" report of the Advisory Committee to the NIH Director BRAIN Initiative Working Group 2.0.

3+ years industry experience in bioinformatics analysis and applications development. Strong knowledge and demonstrated applications of modern data science…
From Seattle Genetics - Thu, 17 Sep 2020 06:16:33 GMT - View all Bothell, WA jobs

£60000 - £97000 per annum: CK Group: CK Clinical are looking for a Bioinformatician to join a very exciting small Biotech. This role will be based in the London area with some... Hertfordshire

Funding Opportunity RFA-NS-21-010 from the NIH Guide for Grants and Contracts. Reissue of RFA-NS-20-010: The purpose of this funding opportunity announcement (FOA) is to support preclinical optimization and development of safe, effective, and non-addictive small molecule and biologic therapeutics to treat pain. The goal of the program is to accelerate the optimization and development of promising small molecule and biologic hits/leads towards clinical trials. Applicants must have a promising hit/lead, robust biological rationale for the intended approach, and identified assays for optimization of the agent. The scope of this program includes optimization and early development activities, IND-enabling studies, and assembly of Investigational New Drug (IND) application. This is a milestone-driven phased cooperative agreement program involving participation of NIH program staff in the development of the project plan and monitoring of research progress.

Notice NOT-OD-20-174 from the NIH Guide for Grants and Contracts